Zileuton
Who holds supplier records for Zileuton? 7 organisations hold a current record for Zileuton: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Zileuton: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zileuton
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Zileuton. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 26446 · latest filing Sept 2012
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25805 · latest filing Mar 2012
- ERREGIERRE SPAItaly Company GMP cert on recordActive DMF 26995 · latest filing Mar 2013
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 24334 · latest filing Apr 2011
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 24827 · latest filing Apr 2011
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 35137 · latest filing Dec 2020
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 31578 · latest filing Jul 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Zileuton are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Czechia · Inactive DMF 27679, 32110 · filed Sept 2017
Overview
Zileuton is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL93).
Chemical identity
- IUPAC name
- 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
- Canonical SMILES
- CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
- InChIKey
- MWLSOWXNZPKENC-UHFFFAOYSA-N
- Synonyms
- A-64077, ABBOTT-64077, NSC-730712, NSC-759277, Zileuton, Zyflo, Zyflo cr, Leutrol, Zileutonum, CHEBI:10112, NSC730712, Abbot 64077
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- 5-Lipoxygenase Inhibitor
- Mechanism of action
- 5-Lipoxygenase Inhibitors
- Physiologic effect
- Decreased Leukotriene Production
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Zileuton?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Zileuton: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Emcure Pharmaceuticals Limited (India), ERREGIERRE SPA (Italy), MATRIX PHARMACORP PRIVATE LTD (India), MSN Laboratories Private Limited (India), OPTIMUS DRUGS PRIVATE LTD (India) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Zileuton Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 26446), Emcure Pharmaceuticals Limited (DMF 25805), ERREGIERRE SPA (DMF 26995), MATRIX PHARMACORP PRIVATE LTD (DMF 24334), MSN Laboratories Private Limited (DMF 24827), OPTIMUS DRUGS PRIVATE LTD (DMF 35137) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 31578). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Zileuton records mean?
1 organisation has only inactive Type II DMFs for Zileuton. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Zileuton supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Zileuton?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.